Skip to content

Early Detection of Anaemia During the Maternity

The Early Detection of Anaemia During the Maternity Decreases the Anaemia at the End of the Maternity.

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00827463
Acronym
anémie
Enrollment
80
Registered
2009-01-22
Start date
2009-01-31
Completion date
2009-12-31
Last updated
2016-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia

Keywords

aneamia, aneamia during the maternity

Brief summary

Estimate the efficiency of a strategy of premature screening of the maternal anaemia during the first quarter of pregnancy versus the usual strategy of screening of the anaemia during the sixth month.

Detailed description

A part of the patient will have a NFS and dosage of the cast-iron, during the results of the beginning of the pregnancy at the first quarter. The other part of the patients will have a NFS and at the first quater of the pregnancy. All the patient will have a NFS at the results of the sixth month of the pregnancy. A NFS will be done during the results at the end of the pregnancy like we do now. Then a NFS at 48 hours after the birth. A treatment with iron will be done and according to the results

Interventions

BIOLOGICALdosage of the NFS and iron

a blood test will be made.

Sponsors

University Hospital, Limoges
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Every patient followed at the HME at the beginnig of the pregnancy

Exclusion criteria

* pregnency women who don't speak french * pregnancy women affected by béta thalassemia * pregnancy woman having had a périconceptionnel treatment against the anaemia

Design outcomes

Primary

MeasureTime frame
primary outcomes: is the rate of heamophilia at the end of the pregnancy.six months

Secondary

MeasureTime frame
Secondary outcomes: - the percent of treatment of intravenous irons during the pregnancy and the following layers. - the percent of transfusion and the following layers.6 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026